What is the recommended diagnostic workup and treatment plan for a 34-year-old man with an olfactory neuroblastoma located in the left sphenoethmoid region?

Recommended Management for Olfactory Neuroblastoma in the Left Sphenoethmoid Region

This 34-year-old man requires comprehensive imaging with CT and MRI of the paranasal sinuses and skull base, followed by surgical resection with negative margins and adjuvant radiotherapy as the standard of care 1, 2.

Diagnostic Workup

Initial Imaging

• CT and MRI of paranasal sinuses and skull base are essential for diagnosis and staging 1. MRI provides superior soft tissue contrast resolution to assess:

  • Extent of tumor invasion into the anterior cranial fossa (olfactory neuroblastomas have a propensity for intracranial extension given their origin from the olfactory epithelium at the cribriform plate) 3
  • Orbital involvement
  • Perineural spread
  • Dural involvement
  • Bone marrow infiltration

• MRI orbits, face, and neck without and with IV contrast is the preferred modality for local staging, as it better delineates soft tissue extent and evaluates regional extension to orbits, dura, and brain 3

Systemic Staging

• CT chest with IV contrast to screen for pulmonary metastases, particularly important in advanced stage disease 3. Chest radiography is inadequate (only 28% sensitivity) 3

• FDG-PET/CT from skull base to mid-thigh should be considered for comprehensive staging, though its value is limited if the tumor demonstrates poor FDG uptake 3

Cervical Nodal Assessment

• Ultrasound of the neck coupled with fine-needle aspiration/core-needle biopsy is a reliable adjunct for nodal staging (sensitivity 77.8%-96.8%, specificity 68.75%-97%) 3

Histopathological Analysis

• Requires specialized pathology expertise 1
• Hyams histological grade is the main prognostic factor and must be determined 1, 4
• Look for: small round blue cells in lobular architecture, chromogranin/synaptophysin positivity, mitotic activity, necrosis, and Ki-67 index 4

Treatment Algorithm

Primary Treatment Strategy

For endoscopically resectable disease:

• Endoscopic skull base surgery (ESBS) with negative margins is the preferred approach 5, 2
• ESBS demonstrates significantly shorter operating time, faster ambulation, shorter hospitalization, and less blood loss compared to craniotomy 5
• Followed by adjuvant radiotherapy (intensity-modulated radiation therapy/IMRT technique) 2

For locally advanced disease with significant orbital or intracranial involvement:

• Induction chemotherapy followed by craniotomy combined with ESBS 6, 5
• Then postoperative radiotherapy 5

For unresectable cases:

• Chemoradiotherapy 5

Adjuvant Therapy Considerations

• Adjuvant radiotherapy should be strongly considered for:

  • High Hyams grade tumors 6
  • Advanced tumor stage 6
  • Positive surgical margins 6

• Chemotherapy may be considered in high-grade or unresectable forms 1

Regional Neck Management

• Regional metastasis to the neck may be present at diagnosis or occur in delayed fashion 6
• Address through elective neck dissection or radiation 6

Critical Pitfalls to Avoid

1. Misdiagnosis on limited biopsy: Ectopic olfactory neuroblastoma can mimic neuroendocrine carcinoma on initial biopsy; complete resection and thorough histopathological evaluation are essential for accurate diagnosis and Hyams grading 4

2. Inadequate imaging: Do not rely on chest radiography for metastatic screening—it misses 72% of pulmonary metastases detected by CT 3

3. Insufficient follow-up: At least 20 years of surveillance is mandatory due to the risk of late recurrence 1. This tumor has a pattern of slow growth and delayed local recurrences 2

4. Underestimating intracranial extension: Given the sphenoethmoid location, carefully assess for anterior cranial fossa invasion, which is common with olfactory neuroblastomas 3

Expected Outcomes

With appropriate multimodal treatment (endoscopic resection + adjuvant radiotherapy):

• 5-year overall survival: 92.9%
• 10-year overall survival: 82.5%
• 5-year disease-free survival: 77.3%
• 10-year local control: 80.2% 5

Hyams grade I disease in particular carries an excellent prognosis with combined endoscopic surgery and radiotherapy 4.

Multidisciplinary Approach

Discussion in a specialized multidisciplinary tumor board is mandatory given the rarity of this tumor (only 2% of sinonasal tumors, 6% of sinonasal cancers) 3, 1. The team should include head and neck surgery, neurosurgery, radiation oncology, medical oncology, and specialized pathology.